RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Daily Briefing

Weekly review: Leapfrog grades 2,862 hospitals 'A' to 'F.' How did yours fare?


Flu continues to surge throughout the United States, five unusual Covid-19 symptoms and how to treat them, and more.

The flu continues to surge throughout the US. See it charted. (Monday, November 14)

Many different respiratory viruses are circulating throughout the United States, but the flu is responsible for a "significant proportion" of that circulation, according to CDC, all while many hospitals are dealing with surges of pediatric respiratory syncytial virus patients.

The long-awaited trial results of Roche's Alzheimer's drug (Tuesday, November 15)

Gantenerumab, an experimental Alzheimer's drug developed by Roche Holding AG, failed to significantly slow cognitive decline in people with early Alzheimer's, according to two new studies.

Are bundled payments value-based care? (Wednesday, November 16)

It's easy to assume bundled payments are value-based care, many do. But in a recent conversation between Advisory Board experts, we found ourselves at odds. Our main takeaway? It's more nuanced than a simple yes or no.

Leapfrog grades 2,862 hospitals 'A' to 'F.' How did yours fare? (Thursday, November 17)

The Leapfrog Group on Tuesday released its fall 2022 Leapfrog Hospital Safety Grades, with around 30% of hospitals earning an "A" grade.

5 unusual symptoms of Covid-19 (and how to treat them) (Friday, November 18)

While most people are familiar with the "telltale symptoms of a Covid-19 infection," some people develop "uncommon manifestations" of the disease, including "hairy tongues, purple toes, welts that sprout on their faces," and more, Dani Blum writes for the New York Times.

 

 

 


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.